BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lan L, Chen YL, Zhang H, Jia BL, Chu YJ, Wang J, Tang SX, Xia GD. Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety. World J Gastroenterol 2014; 20(32): 11422-11428 [PMID: 25170231 DOI: 10.3748/wjg.v20.i32.11422] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Zhan T, Dong Z, Yi L, Zhang Y, Sun H, Zhang H, Wang J, Chen Y, Huang Y, Xu S. Tandospirone prevents stress-induced anxiety-like behavior and visceral hypersensitivity by suppressing theta oscillation enhancement via 5-HT1A receptors in the anterior cingulate cortex in rats. Front Cell Neurosci 2022;16:922750. [DOI: 10.3389/fncel.2022.922750] [Reference Citation Analysis]
2 Tang VM, Davies SJC. Anxiolytics: Misuse, Dependence, and Withdrawal Syndromes. NeuroPsychopharmacotherapy 2022. [DOI: 10.1007/978-3-030-62059-2_405] [Reference Citation Analysis]
3 Bosman M, Elsenbruch S, Corsetti M, Tack J, Simrén M, Winkens B, Boumans T, Masclee A, Keszthelyi D. The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2021;6:459-73. [PMID: 33765447 DOI: 10.1016/S2468-1253(21)00023-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
4 Tang VM, Davies SJC. Anxiolytics: Misuse, Dependence, and Withdrawal Syndromes. NeuroPsychopharmacotherapy 2021. [DOI: 10.1007/978-3-319-56015-1_405-1] [Reference Citation Analysis]
5 Fukudo S, Okumura T, Inamori M, Okuyama Y, Kanazawa M, Kamiya T, Sato K, Shiotani A, Naito Y, Fujikawa Y, Hokari R, Masaoka T, Fujimoto K, Kaneko H, Torii A, Matsueda K, Miwa H, Enomoto N, Shimosegawa T, Koike K. Evidence-based clinical practice guidelines for irritable bowel syndrome 2020. J Gastroenterol 2021;56:193-217. [PMID: 33538894 DOI: 10.1007/s00535-020-01746-z] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 19.5] [Reference Citation Analysis]
6 Xuan L, Zhou J, Yi L, Xu S. Up-regulation of HTR1A reverses stress-induced visceral hypersensitivity through modulating interactions among the anterior cingulate cortex, insular cortex and hippocampus. Pteridines 2020;31:165-73. [DOI: 10.1515/pteridines-2020-0016] [Reference Citation Analysis]
7 Masuy I, Pannemans J, Tack J. Irritable bowel syndrome: diagnosis and management. Minerva Gastroenterol Dietol 2020;66. [DOI: 10.23736/s1121-421x.19.02640-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
8 Badihian N, Yaghini O, Badihian S, Shahsanai A, Saneian H. Comparison of the Efficacy of Buspirone and Placebo in Childhood Functional Abdominal Pain: A Randomized Clinical Trial. Am J Gastroenterol 2020;115:756-65. [PMID: 32221160 DOI: 10.14309/ajg.0000000000000589] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Yi L, Sun H, Zhang H, Chen Y, Zhou L, Xuan L, Zhan T, Jiang Y, Xu S. Down-regulation of HTR1A-modulated ACC activation contributes to stress-induced visceral hyperalgesia in rats. Neurogastroenterol Motil 2019;31:e13620. [PMID: 31121088 DOI: 10.1111/nmo.13620] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
10 Törnblom H, Drossman DA. Psychotropics, Antidepressants, and Visceral Analgesics in Functional Gastrointestinal Disorders. Curr Gastroenterol Rep 2018;20:58. [PMID: 30397821 DOI: 10.1007/s11894-018-0664-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
11 Gao GZ, Hao YX. Treatment of irritable bowel syndrome with neurotransmitter mediators. Shijie Huaren Xiaohua Zazhi 2017; 25(34): 3025-3031 [DOI: 10.11569/wcjd.v25.i34.3025] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Thorkelson G, Bielefeldt K, Szigethy E. Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD. Inflamm Bowel Dis 2016;22:1509-22. [PMID: 27167571 DOI: 10.1097/MIB.0000000000000734] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
13 Horiguchi M, Miyauchi M, Neugebauer NM, Oyamada Y, Meltzer HY. Prolonged reversal of the phencyclidine-induced impairment in novel object recognition by a serotonin (5-HT)1A-dependent mechanism. Behavioural Brain Research 2016;301:132-41. [DOI: 10.1016/j.bbr.2015.08.040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
14 Törnblom H, Drossman DA. Centrally Targeted Pharmacotherapy for Chronic Abdominal Pain: Understanding and Management. Gastrointestinal Pharmacology 2016. [DOI: 10.1007/164_2016_106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
15 Yang C, Zhang SS, Li XL, Wang ZF, Zhao LQ. Inhibitory effect of TongXie-YaoFang formula on colonic contraction in rats. World J Gastroenterol 2015; 21(10): 2912-2917 [PMID: 25780288 DOI: 10.3748/wjg.v21.i10.2912] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]